NCT05606042 is a clinical trial of IM Implant in Pelvic Ring Fracture, sponsored by CurvaFix, Inc..

Who is sponsoring NCT05606042?

NCT05606042 is sponsored by CurvaFix, Inc..

What drugs are being tested in NCT05606042?

Interventions in NCT05606042: IM Implant.

What condition does NCT05606042 study?

NCT05606042 studies Pelvic Ring Fracture, Acetabular Fracture, Pelvic Fracture, Pelvic Fracture Acetabulum.

Is NCT05606042 still recruiting?

NCT05606042 is currently terminated. Last updated 20 March 2026.

Last reviewed 2026-03-20 · How we verify

NCT05606042

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Curvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market Evaluation

Terminated Last updated 20 March 2026

What this trial tests

trial testing IM Implant in Pelvic Ring Fracture in 53 participants. Terminated before completion.

Timeline

24 November 2021

Primary endpoint
9 March 2023

9 March 2023

Quick facts

Lead sponsor	CurvaFix, Inc.
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	53
Start date	24 November 2021
Primary completion	9 March 2023
Estimated completion	9 March 2023
Sites	6 locations across United States

Drugs / interventions tested

IM Implant

Conditions studied

Pelvic Ring Fracture — all drugs for Pelvic Ring Fracture →
Acetabular Fracture — all drugs for Acetabular Fracture →
Pelvic Fracture — all drugs for Pelvic Fracture →
Pelvic Fracture Acetabulum — all drugs for Pelvic Fracture Acetabulum →

Sponsor

CurvaFix, Inc.

Who can join

Eligibility, any sex, with Pelvic Ring Fracture or Acetabular Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, single arm, post-market evaluation to evaluate the use and performance of the IM Implant in a post market setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05606042 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CurvaFix, Inc.
Last refreshed: 20 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05606042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing